RxDoctor Payments Data

Ryan Werntz, MD

Urology · Greenville, SCNPI 1780940023

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,580 of the $14,562 with a category attached, or 72.7%. Photocure Inc accounts for 85.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $9,562 and has fallen 97.3% since, to $258 in 2025.

$14,562in general payments, 2019–2025

Across 51 payments — averaging $285.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Photocure Inc$12K
  • KARL Storz Endoscopy-america$293
  • Coloplast$286
  • Neotract Inc.$266
  • Urogen Pharma, Inc.$217
  • Procept Biorobotics Corporation$189
  • plus $928 from 14 others
$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • QED Therapeutics, Inc.$500

What the payments were for

  • Consulting fees$10,58073%
  • Speaking & faculty fees$1,3139%
  • Travel & lodging$1461%
  • Food & beverage$2,52417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,562 in reported general payments places this provider in the 85th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina

Medicare billing

Part B allowed, 2024
$356,294
Medicare patients
430
Services billed
1,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl51$440
Oxybutynin Chloride39$322
NitrofurantoinNitrofurantoin Macrocrystal12$205
Finasteride15$136
Ciprofloxacin Hcl18$31

Paid to pharmacies, not to this prescriber.

Other urology in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →